Qualitative and Quantitative Requirements for Assessing Prognostic Markers in Prostate Cancer

Molecular prognostic markers are urgently needed in order to improve therapy decisions in prostate cancer. To better understand the requirements for biomarker studies, we re-analyzed prostate cancer tissue microarray immunohistochemistry (IHC) data from 39 prognosis markers in subsets of 50 – >10...

Descripción completa

Detalles Bibliográficos
Autores principales: Burdelski, Christoph, Matuszewska, Aleksandra, Kluth, Martina, Koop, Christina, Grupp, Katharina, Steurer, Stefan, Wittmer, Corinna, Minner, Sarah, Tsourlakis, Maria Christina, Sauter, Guido, Schlomm, Thorsten, Simon, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003445/
https://www.ncbi.nlm.nih.gov/pubmed/27600340
http://dx.doi.org/10.3390/microarrays3020137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003445/
https://www.ncbi.nlm.nih.gov/pubmed/27600340
http://dx.doi.org/10.3390/microarrays3020137

Ejemplares similares